• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性妇科疾病中的CA 125

CA 125 in benign gynecological conditions.

作者信息

Meden H, Fattahi-Meibodi A

机构信息

Department of Obstetrics and Gynecology, University of Göttingen, Germany.

出版信息

Int J Biol Markers. 1998 Oct-Dec;13(4):231-7. doi: 10.1177/172460089801300411.

DOI:10.1177/172460089801300411
PMID:10228907
Abstract

The tumor marker CA 125 was initially thought to be specific for ovarian malignancies. Subsequently it was found to be raised in a variety of benign conditions, including pregnancy, pelvic inflammatory disease, tuberculosis and cirrhosis of the liver. With respect to gynecological tumors, CA 125 may be elevated in benign ovarian cysts, tubo-ovarian abscess, endometriosis, hyperstimulation syndrome, ectopic pregnancy and fibroids. These results demonstrate that CA 125 is a marker of non-specific peritoneal conditions.

摘要

肿瘤标志物CA 125最初被认为是卵巢恶性肿瘤的特异性标志物。随后发现它在多种良性疾病中也会升高,包括妊娠、盆腔炎、肺结核和肝硬化。就妇科肿瘤而言,CA 125在良性卵巢囊肿、输卵管卵巢脓肿、子宫内膜异位症、卵巢过度刺激综合征、宫外孕和子宫肌瘤中也可能升高。这些结果表明,CA 125是非特异性腹膜疾病的标志物。

相似文献

1
CA 125 in benign gynecological conditions.良性妇科疾病中的CA 125
Int J Biol Markers. 1998 Oct-Dec;13(4):231-7. doi: 10.1177/172460089801300411.
2
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases.人附睾蛋白4:一种新型卵巢癌肿瘤标志物——与妇科疾病患者的CA 125及ROMA算法的比较
Tumour Biol. 2011 Dec;32(6):1087-95. doi: 10.1007/s13277-011-0204-3. Epub 2011 Aug 24.
3
Tissue polypeptide-specific antigen and CA 125 as serum tumor markers in ovarian carcinoma.组织多肽特异性抗原和CA 125作为卵巢癌的血清肿瘤标志物
Tumour Biol. 1994;15(6):361-7. doi: 10.1159/000217913.
4
Diagnosis and Management of Adnexal Masses.附件肿物的诊断与管理
Am Fam Physician. 2016 Apr 15;93(8):676-81.
5
CA 125: the past and the future.癌抗原125:过去与未来
Int J Biol Markers. 1998 Oct-Dec;13(4):179-87. doi: 10.1177/172460089801300402.
6
Cirrhotic ascites, ovarian carcinoma, and CA-125.肝硬化腹水、卵巢癌与癌抗原125
South Med J. 1999 Feb;92(2):248-50. doi: 10.1097/00007611-199902000-00019.
7
Usefulness of serum HE4 in endometriotic cysts.血清人附睾蛋白4在子宫内膜异位囊肿中的应用价值
Br J Cancer. 2009 Aug 4;101(3):548. doi: 10.1038/sj.bjc.6605119. Epub 2009 Jun 9.
8
The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis.人附睾蛋白 4、癌抗原 125 及恶性肿瘤风险算法在卵巢癌和子宫内膜异位症中的应用。
Int J Gynecol Cancer. 2012 Feb;22(2):238-44. doi: 10.1097/IGC.0b013e318234f852.
9
[The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].[血清人附睾分泌蛋白4及CA125检测在卵巢恶性肿瘤诊断中的价值]
Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):931-6.
10
Heavy black tea consumption and elevated CA 19-9 and CA 125 levels. A case report on a patient with ovarian endometriotic cysts.大量饮用浓茶与 CA19-9 和 CA125 水平升高。一位卵巢子宫内膜异位囊肿患者的病例报告。
Gynecol Endocrinol. 2019 Jun;35(6):478-480. doi: 10.1080/09513590.2018.1564743. Epub 2019 Feb 6.

引用本文的文献

1
Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population.利用血清脂质组学结合蛋白质生物标志物和机器学习对有症状人群进行卵巢癌早期检测。
Cancer Res Commun. 2025 Sep 1;5(9):1516-1529. doi: 10.1158/2767-9764.CRC-25-0140.
2
Low Serum Cholinesterase Levels Predict Poor Prognosis in Patients with Ovarian Cancer.低血清胆碱酯酶水平预示卵巢癌患者预后不良。
Int J Gen Med. 2025 Feb 25;18:1023-1033. doi: 10.2147/IJGM.S509718. eCollection 2025.
3
Diagnostic role of urine human epididymis protein 4 in ovarian cancer.
尿人附睾蛋白 4 在卵巢癌中的诊断作用。
Biochem Med (Zagreb). 2024 Oct 15;34(3):030502. doi: 10.11613/BM.2024.030502.
4
Pseudo-Meigs syndrome caused by a rapidly enlarging hydropic leiomyoma with elevated CA125 levels mimicking ovarian malignancy: a case report and literature review.由快速增大的水肿性平滑肌瘤伴CA125水平升高引起的假性梅格斯综合征,酷似卵巢恶性肿瘤:一例报告及文献复习
BMC Womens Health. 2024 Aug 7;24(1):445. doi: 10.1186/s12905-024-03285-8.
5
Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location.验证一种用于子宫内膜异位症的体外诊断测试:混杂医疗条件和病变位置的影响。
Int J Mol Sci. 2024 Jul 12;25(14):7667. doi: 10.3390/ijms25147667.
6
Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool.使用微小RNA(miRNA)作为潜在工具进行早期上皮性卵巢癌检测的当前策略。
Front Mol Biosci. 2024 Apr 16;11:1361601. doi: 10.3389/fmolb.2024.1361601. eCollection 2024.
7
mRNA and Protein Expression in Human Fetal Membrane Cells: Potential Biomarkers for Preterm Prelabor Rupture of the Fetal Membranes?mRNA 和蛋白质在人胎膜细胞中的表达:预测未足月胎膜早破的潜在生物标志物?
Int J Mol Sci. 2023 Oct 31;24(21):15826. doi: 10.3390/ijms242115826.
8
CA125 Levels in BRCA mutation carriers - a retrospective single center cohort study.BRCA 基因突变携带者的 CA125 水平 - 一项回顾性单中心队列研究。
BMC Cancer. 2023 Jul 1;23(1):610. doi: 10.1186/s12885-023-11116-6.
9
MicroRNAs as Potential Biomarkers in Gynecological Cancers.微小RNA作为妇科癌症的潜在生物标志物
Biomedicines. 2023 Jun 13;11(6):1704. doi: 10.3390/biomedicines11061704.
10
Next Generation of Ovarian Cancer Detection Using Aptamers.基于适体的新一代卵巢癌检测方法。
Int J Mol Sci. 2023 Mar 28;24(7):6315. doi: 10.3390/ijms24076315.